DCAMKL1 shRNA Plasmid (h) from Santa Cruz Biotechnology, Inc.

10410 Finnell Street

Dallas, Texas 75220

United States

Phone: 1-800-457-3801
831-457-3801

(1) DCLK1 Regulates Tumor Stemness and Cisplatin Resistance in Non-small Cell Lung Cancer via ABCD-Member-4Molecular therapy oncolyticsSeptember 25, 2020Panneerselvam J, Mohandoss P, Patel R, Gillan H, Li M, Kumar K, Nguyen D, Weygant N, Qu D, Pitts K, et al.

(2) DCLK1-Isoform2 Alternative Splice Variant Promotes Pancreatic Tumor Immunosuppressive M2-Macrophage PolarizationMolecular cancer therapeuticsJuly 1, 2020Chandrakesan P, Panneerselvam J, May R, Weygant N, Qu D, Berry WR, Pitts K, Stanger BZ, Rao CV, Bronze MS, et al.

(4) Dclk1, a tumor stem cell marker, regulates pro-survival signaling and self-renewal of intestinal tumor cellsMolecular cancerFebruary 1, 2017Chandrakesan P, Yao J, Qu D, May R, Weygant N, Ge Y, Ali N, Sureban SM, Gude M, Vega K, et al.

(6) miR-613 inhibits the growth and invasiveness of human hepatocellular carcinoma via targeting DCLK1Biochemical and biophysical research communicationsMay 13, 2016Wang W, Zhang H, Wang L, Zhang S, Tang M.

DCAMKL1 shRNA Plasmid (h)